Use "Ctrl+F" to search this page.
Topic |
Guidance/Reference |
Doc/
source
|
HRPP Policy
Ch(s) |
|
Commonly Used Acronyms
|
AID-22 |
|
Children in Research |
Additional Protections - Inclusion of Children (FDA)
Additional Protections - Inclusion of Children (OHRP)
|
GUI-9
GUI-1 |
5, 8, 9, 12, 14 |
Research Involving a Placebo Arm (implications of March 2013 FDA final rule, subpart D) |
IRB memo |
Children Involved as Subjects in Research - "407" Review Process |
OHRP |
Consent for Children and Consenting Minors |
GUI-C24 |
Parental Permission |
GUI-C34 |
Risk Level in Pediatric Research |
GUI-01042 |
Compassionate Use |
"Compassionate" and "Humanitarian" Use [FDA] |
GUI-36m |
5 |
Expanded Access to Investigational Drugs and Devices
|
GUI-19m |
Confidentiality
|
Certificates of Confidentiality (COC) |
OHRP |
6, 11 |
Confidentiality - Administrative Panel (IRB) Proceedings |
RPH |
6 |
Privacy and Confidentiality (HRPP Ch 11) |
HRPP 11 |
11 |
|
Faculty - Policy on Conflict of Commitment & Interest |
RPH |
2, 3,12 |
IRB Members - Conflicting Interests
IRB Members - Conflict of Interest Declaration |
GUI-15
RPT-I1 |
6 |
|
Consent Form Do's & Don'ts (a practical guide) |
AID-C1 |
12 |
|
GUI-C27 |
General Rqmnts for Informed Consent Medical
General Rqmnts for Informed Consent Nonmedical |
GUI-C41
GUI-C41n |
|
IRB web |
|
APRS web |
Observation of the Consenting Process - Checklist |
CHK-C15 |
Parental Permission |
GUI-C34 |
|
GUI-C2 |
|
GUI-32 |
Short Form Consent Process |
IRB web |
|
Data and Safety Monitoring - Guidance
DSM Plan - eProtocol Help & Hints |
GUI-P20 |
3, 9, 11, 15 |
|
Data Security - Secure Computing Guidelines
Retention of and Access to Research Data |
ISO web
RPH |
3, 9, 11, 15 |
|
FAQs About Medical Devices [FDA] |
FDA |
5 |
Frequently Asked Questions About Medical Devices - FDA Information Sheet |
FDA |
Significant Risk and Non-Significant Risk Medical Devices Studies - Stanford Guidance |
GUI-7m |
Significant Risk and Nonsignificant Risk Medical Device Studies - FDA Information Sheet |
FDA |
Special Considerations for the Oversight of Research Protocols in FDA-regulated Drug or Device Studies
|
GUI-26m |
Sponsor-Investigator Research when the STANFORD Investigator holds the IDE |
GUI-5m |
STANFORD investigator is the sponsor on a nonsignificant risk (NSR) device study
|
GUI-41m |
|
Guidelines for Studies Involving Human Volunteers Receiving Potentially Addicting Drugs |
RPH |
5 |
Orphan Drugs |
FDA |
Security and Controlled Access: Drugs and Biologics |
GUI-35m |
Special Considerations for the Oversight of Research Protocols in FDA-regulated Drug or Device Studies
|
GUI-26m |
Sponsor-Investigator Research when the STANFORD Investigator holds the IND |
GUI-3m |
|
Emergency Use of a Test Article - Guidance
Emergency Use of a Test Article - Web Page |
GUI-6
IRB web |
5.8 |
Expanded Access to
Investigational Drugs and Devices |
Expanded Access to Investigational Drugs and Devices - Guidance
Expanded Access to Investigational (Test) Articles - Brochure |
GUI-19m
GUI-B1m |
5.8 |
Federal Agency Requirements
[DoD, DON, DOE, etc.] |
Other Federal Agencies - Additional Requirements:
DoD, DON, ED, DOE, DOJ, EPA, NSF, PHS |
GUI-42 |
|
DOE - Protection of Personally Identifiable Information (PII) - eProtocol Required Attachment |
APP-14 |
|
Genomic Data Sharing
(NIH grant info) |
NIH Genomic Data Sharing for NIH Grant Submission
|
GUI-G1 |
|
FAQs for Genomic Data Sharing |
IRB web |
|
|
HIPAA and PHI
HIPAA at Stanford |
GUI-3
IRB web |
4, 11 |
Human Subject Research |
Determination of Human Subject Research: Application to IRB |
APP-H8 |
1, 3 |
Does My Project Need IRB Review? |
FLW-H4 |
What Qualifies as Human Subject Research |
GUI-H12 |
Quality Assessment & Quality Improvement (QA/QI) |
AID-H16 |
|
Humanitarian Use Device |
GUI-36m |
|
|
Criteria for IRB Approval of Research: Medical
Criteria for IRB Approval of Research: Nonmedical |
GUI-40
GUI-40n |
7 |
Exempt Review Categories |
GUI-4 |
Expedited Review Categories |
GUI-44 |
Obtaining Additional Expertise or an Expert Consultant |
GUI-12 |
Guidelines for IRB Members on Conflicting Interests |
GUI-15 |
IRB Meeting Schedules |
AID-18 |
IRB Member Conflict of Interest Declaration |
RPT-I1 |
IRB Authority |
Charge to Panel on Human Subjects Research-Medical
|
CHG-1 |
1, 6 |
Charge to Panel on Human Subjects Research - Nonmedical
|
CHG-2 |
Confidentiality of Panel (IRB) Proceedings
|
RPH |
IRB Rosters |
IRB web |
International Research |
International Compilation of Human Research Protections (OHRP) - laws, regulations, guidelines on human subjects research in over 100 countries; standards (international, regional) |
OHRP |
1 |
MTA |
Material Transfer Agreements |
OTL |
|
Multi-Site Research |
Cooperative Research: Letter of Agreement |
GUI-31 |
13 |
|
Ethical Considerations |
GUI-39 |
10, 12, 14
|
Stanford University Job Aid: Paying Human Subjects |
AID-9 |
|
California Penal Code: Section 3501 - 3523 |
GUI-38 |
9, 12 |
OHRP Guidance on Involvement of Prisoners in Research |
GUI-10 |
Radiation
|
Preparing Research Proposals Involving Diagnostic Use of Ionizing Radiation |
APRS web |
|
Use of Radiology Devices and Radioactive Materials |
GUI |
|
Recruitment |
Advertisements: Appropriate Language - Recruitment Material |
GUI-16 |
10, 20 |
General guidance on participant recruitment |
GUI-33 |
Use of Employees or Laboratory Personnel as Research Subjects |
RPH |
Telephone Screening of Potential Subjects |
GUI-15 |
|
Events and Information that Require Prompt Reporting to the IRB |
GUI-P13 |
3 |
Unanticipated Adverse Device Effect (UADE) |
GUI-P14 |
3 |
Risk |
Special Considerations about Risks in Behavioral and Social Sciences Research |
GUI-14n |
9 |
|
Data security - Secure Computing Guidelines |
Stanford ISO web |
4, 11
|
Security and Controlled Access: Drugs and Biologics |
GUI-35m |
Short Form
Consent |
Short Form Consent Process - Guidance |
GUI-C39 |
12 |
Short Form Consent Process - Web Page |
IRB web |
Sponsor-Investigator
Research
(SIR) |
Requirements for New, Continuing Review and Final Report |
AID-23m |
5, 15 |
When the STANFORD Investigator holds the IDE |
GUI-5m |
When the STANFORD Investigator holds the IND |
GUI-3m |
When the STANFORD Investigator is the sponsor on a nonsignificant risk (NSR) device study |
GUI-41m |
SIR Self-Assessment Form - IND |
AID-40m |
SIR Self-Assessment Form - IDE |
AID-41m |
Students |
Special Considerations about Risks in Behavioral and Social Sciences Research |
GUI-14n |
9, 15 |
Use of Human Subjects in Student Projects, Pilot Studies, Oral Histories and QA/QI Projects |
RPH |
Study Design |
Evaluating Sound Study Design |
GUI-17 |
1 |
Terminology |
Clinical Trials Terms |
AID-20m |
|
Tissue & Samples |
Data and Tissue Repositories |
GUI |
11, 12, 13 |
Transplantation of Human Fetal Tissue |
GUI-2m |
Training |
Training in the Protection of Human Subjects in Research |
RPH |
4 |
|
Regulations for Waiver or Alteration of Consent Requirements |
GUI-C2 |
12 |
Women |
Research Involving Pregnant Women, Fetuses, and Neonates |
GUI-8 |
9, 12 |
Women as Subjects in Research |
RPH |